Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lauren M. Moore
Nuclear IRF-1 Expression as a Mechanism to Assess “Capability” to Express PD-L1 and Response to PD-1 Therapy in Metastatic Melanoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Melanoma-Specific MHC-II Expression Represents a Tumour-Autonomous Phenotype and Predicts Response to Anti-Pd-1/Pd-L1 Therapy
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Testing PD-1/PD-L1 Expression in Cancer Therapy: Pathologic Insights and Economic Sustainability
Archives of Pathology and Laboratory Medicine
Medicine
Forensic Medicine
Pathology
Medical Laboratory Technology
Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy
Oncolytic Virotherapy
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Breast Care
Surgery
Oncology
Microsatellite Instability Status Predicts Response to Anti-Pd-1/Pd-L1 Therapy Regardless the Histotype: A Comment on Recent Advances
Bosnian Journal of Basic Medical Sciences
Medicine
Complete Response to Anti-Pd-1 Antibody Monotherapy in Metastatic Melanoma-Can Therapy Be Discontinued? A Review of Current Literature
Journal of Cancer Biology and Therapeutics
ADAM10 and ADAM17 Cleave PD-L1 to Mediate PD-(L)1 Inhibitor Resistance
OncoImmunology
Oncology
Allergy
Immunology
Reply to ‘Challenging PD-L1 Expressing Cytotoxic T Cells as a Predictor for Response to Immunotherapy in Melanoma’
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
OR12: Expression and Localization of PD‐1 and PD‐L1 in Mouse Testes
American Journal of Reproductive Immunology
Gynecology
Reproductive Medicine
Immunology
Obstetrics
Allergy